The Coronary Heart Disease Diagnostic Imaging Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Modality (Computed Tomography, Nuclear Medicine, Ultrasound, X rays, Magnetic Resonance Imaging), By End-user (Hospitals, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers).
The coronary heart disease diagnostic imaging devices market in 2025 caters to the demand for advanced medical imaging technologies used in the diagnosis and assessment of coronary artery disease, myocardial infarction, and other cardiovascular conditions. Diagnostic imaging modalities include coronary angiography, computed tomography angiography (CTA), cardiac magnetic resonance imaging (MRI), and nuclear imaging techniques, such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET). These imaging devices enable non-invasive visualization of coronary arteries, myocardial perfusion, and cardiac function, providing essential information for disease diagnosis, risk stratification, and treatment planning. Market dynamics are driven by factors such as the increasing prevalence of coronary heart disease, the aging population, and technological advancements in cardiac imaging for improved diagnostic accuracy and patient outcomes. Collaboration between medical device manufacturers, cardiologists, and imaging specialists drives innovation and market growth in coronary heart disease diagnostic imaging devices, supporting early detection and intervention in cardiovascular disease management.
The market report analyses the leading companies in the industry including Analogic Corp, Canon Medical Systems Corp, Fujifilm, GE, Hitachi, Koninklijke Phillips, Siemens, Toshiba, and Others.
A prominent trend in the Coronary Heart Disease Diagnostic Imaging Devices market is the continuous advancements in imaging modalities, such as coronary computed tomography angiography (CCTA), cardiac magnetic resonance imaging (MRI), and positron emission tomography (PET) scanning. These technological innovations enable more accurate and comprehensive assessment of coronary artery anatomy, myocardial perfusion, and cardiac function, leading to improved diagnostic accuracy and patient risk stratification. Additionally, the integration of artificial intelligence (AI) algorithms into diagnostic imaging devices enhances image interpretation, reduces interpretation time, and assists clinicians in detecting and characterizing coronary artery lesions and myocardial ischemia with greater precision.
A key driver for the Coronary Heart Disease Diagnostic Imaging Devices market is the increasing prevalence and burden of coronary heart disease (CHD) globally. CHD remains one of the leading causes of morbidity and mortality worldwide, contributing to significant healthcare costs and economic burden. The rising incidence of risk factors such as hypertension, diabetes, obesity, and sedentary lifestyles further fuels the prevalence of CHD and underscores the importance of early and accurate diagnosis for timely intervention and risk stratification. Diagnostic imaging devices play a crucial role in the detection, characterization, and management of CHD by enabling non-invasive visualization of coronary anatomy and assessment of myocardial function, ischemia, and viability.
An opportunity for the Coronary Heart Disease Diagnostic Imaging Devices market lies in the integration of multimodal imaging and hybrid imaging techniques for comprehensive cardiac assessment. Combining different imaging modalities, such as CCTA, cardiac MRI, nuclear imaging, and invasive coronary angiography, into hybrid imaging platforms offers complementary information and enhances the diagnostic accuracy and clinical utility of cardiac imaging studies. Hybrid imaging approaches, such as PET/CT and PET/MRI, enable simultaneous assessment of coronary anatomy, myocardial perfusion, metabolism, and inflammation, providing a comprehensive evaluation of CHD pathophysiology. By investing in the development of integrated multimodal imaging systems and promoting interdisciplinary collaboration among cardiologists, radiologists, and nuclear medicine specialists, manufacturers can capitalize on the growing demand for advanced imaging solutions for CHD diagnosis and management.
The hospitals segment is the largest in the Coronary Heart Disease Diagnostic Imaging Devices Market by end-user. This is because hospitals are typically equipped with advanced imaging technology and have the necessary infrastructure to conduct a wide range of diagnostic procedures, including imaging for coronary heart disease. Hospitals serve a large patient base, particularly those with complex or acute conditions requiring frequent and detailed imaging. Additionally, hospitals often have specialized departments like cardiology, which increases the demand for imaging devices such as CT scans, MRIs, and X-rays for diagnosing heart diseases. The availability of funding and the need for immediate, high-quality diagnostic services make hospitals the dominant end-user segment in this market.
The Computed Tomography (CT) modality is expected to be the fastest growing in the Coronary Heart Disease Diagnostic Imaging Devices Market over the forecast period to 2034. This growth is attributed to the increasing demand for non-invasive and accurate diagnostic tools for coronary heart disease. CT imaging, particularly coronary CT angiography (CTA), has become a preferred choice for evaluating coronary artery disease due to its high-resolution imaging capabilities, quick results, and ability to provide comprehensive information about heart and blood vessel health. Moreover, advancements in CT technology, such as the development of low-dose CT scans, contribute to the modality's increasing adoption. As healthcare providers look for efficient and precise diagnostic methods, the CT segment is poised for significant growth in the coming years.
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Analogic Corp
Canon Medical Systems Corp
Fujifilm
GE
Hitachi
Koninklijke Phillips
Siemens
Toshiba
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Coronary Heart Disease Diagnostic Imaging Devices Market, encompassing current market size, growth trends, and forecasts till 2034.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Coronary Heart Disease Diagnostic Imaging Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Coronary Heart Disease Diagnostic Imaging Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Coronary Heart Disease Diagnostic Imaging Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Coronary Heart Disease Diagnostic Imaging Devices Market Outlook By Type, $ Million, 2021 to 2030
3.3 Coronary Heart Disease Diagnostic Imaging Devices Market Outlook By Product, $ Million, 2021 to 2030
3.4 Coronary Heart Disease Diagnostic Imaging Devices Market Outlook By Application, $ Million, 2021 to 2030
3.5 Coronary Heart Disease Diagnostic Imaging Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Coronary Heart Disease Diagnostic Imaging Devices Market Industry
4.2 Key Market Trends in Coronary Heart Disease Diagnostic Imaging Devices Market Industry
4.3 Potential Opportunities in Coronary Heart Disease Diagnostic Imaging Devices Market Industry
4.4 Key Challenges in Coronary Heart Disease Diagnostic Imaging Devices Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Coronary Heart Disease Diagnostic Imaging Devices Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Coronary Heart Disease Diagnostic Imaging Devices Market Outlook By Segments
7.1 Coronary Heart Disease Diagnostic Imaging Devices Market Outlook by Segments
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
8 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis And Outlook To 2030
8.1 Introduction to North America Coronary Heart Disease Diagnostic Imaging Devices Markets in 2024
8.2 North America Coronary Heart Disease Diagnostic Imaging Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Coronary Heart Disease Diagnostic Imaging Devices Market size Outlook by Segments, 2021-2030
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
9 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Analysis And Outlook To 2030
9.1 Introduction to Europe Coronary Heart Disease Diagnostic Imaging Devices Markets in 2024
9.2 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size Outlook By Segments, 2021-2030
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
10 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Markets in 2024
10.2 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market size Outlook by Segments, 2021-2030
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
11 South America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis And Outlook To 2030
11.1 Introduction to South America Coronary Heart Disease Diagnostic Imaging Devices Markets in 2024
11.2 South America Coronary Heart Disease Diagnostic Imaging Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Coronary Heart Disease Diagnostic Imaging Devices Market size Outlook by Segments, 2021-2030
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
12 Middle East And Africa Coronary Heart Disease Diagnostic Imaging Devices Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Coronary Heart Disease Diagnostic Imaging Devices Markets in 2024
12.2 Middle East and Africa Coronary Heart Disease Diagnostic Imaging Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Coronary Heart Disease Diagnostic Imaging Devices Market size Outlook by Segments, 2021-2030
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Analogic Corp
Canon Medical Systems Corp
Fujifilm
GE
Hitachi
Koninklijke Phillips
Siemens
Toshiba
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Modality
Computed Tomography
Nuclear Medicine
Ultrasound
X rays
Magnetic Resonance Imaging
By End-user
Hospitals
Specialty Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Coronary Heart Disease Diagnostic Imaging Devices Market Size is valued at 1.94 Billion in 2024 and is forecast to register a growth rate (CAGR) of 6.3% to reach 3.6 Billion by 2034.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Analogic Corp, Canon Medical Systems Corp, Fujifilm, GE, Hitachi, Koninklijke Phillips, Siemens, Toshiba
Base Year- 2024; Estimated Year- 2025; Historic Period- 2019-2024; Forecast period- 2025 to 2034; Currency: Revenue (USD); Volume